The Campbell’s Company (CPB US)
CPB US$20.59
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 20.59
- Change
- ▼ -0.09 (-0.44)
- Bid / Ask
- 20.58 - 20.59
- Volume
- 731,051
- Turnover
- 12,808,659
- Open
- 20.49
- Day Range
- 20.36 - 20.63
- VWAP
- 20.53
- Prev Close
- 20.68
- Last Trade
- 28/10 4:00pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Consumer Defensive
- Shares Issued
- 298,234,693
- NTA/Share
- -19.00
- Last Dividend
- 0.25
- Dividend Ex Date
- 1 OCT 2026
- Dividend Pay Date
- 2 NOV 2026
Current (USD) · FY2026
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 9,744.00
- EBITDA
- 1,265.00
- Profit
- 403.00
- Earnings Per Share (EPS)
- 1.31
- Dividend Per Share (DPS)
- 1.56
- Yield %
- 6.68
- Market Cap
- 6,140.65
- Price to Earnings Ratio (P/E)
- 15.71
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 9,804.31
- EBITDA
- 1,451.67
- Profit
- 524.42
- Earnings Per Share (EPS)
- 1.70
- Dividend Per Share (DPS)
- 1.00
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Wide
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 22 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 25.75 Fair value 30.98 One-star price 37.28
Morningstar Quantitative Rating as of 22 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 30.98
- Price / Fair Value
- 0.69
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 22 OCT 2026. The slider runs from the five-star price (25.75) to the one-star price (37.28).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 21.27 |
| Price - 12 month high | 32.03 |
| Price - 12 month low | 18.61 |
| Pricing date | 21 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 7.66 |
| Market capitalization | 6,340.47 |
| 12 Month High price date | 21 NOV 2025 |
| 12 Month Low price date | 7 OCT 2026 |
| Volume - avg. trading volume for the last 3 months | 7.21 |
| Price - 1 Day % Change | 8.74% |
| Price - 13 week price percent change | -2.79% |
| Price - 26 week price percent change | 2.16% |
| Price - 5 Day % Change | 7.21% |
| Price - 52 week price percent change | -32.22% |
| Price - YTD price percent change | -24.20% |
| Price % Change Month To Date | 5.24% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 1.310 |
| EPS excluding extraordinary items - trailing 12 month | 1.310 |
| EPS Normalized - most recent fiscal year | 2.170 |
| Revenue/share - most recent fiscal year | 32.480 |
| Revenue/share - trailing 12 month | 32.480 |
| Book value per share - most recent fiscal year | 12.911 |
| Book value per share - most recent quarter | 12.911 |
| Book value (tangible) per share - most recent fiscal year | -19.004 |
| Book value (tangible) per share - most recent quarter | -19.004 |
| Cash per share - most recent fiscal year | 1.321 |
| Cash per share - most recent quarter | 1.321 |
| Cash Flow per share - most recent fiscal year | 4.000 |
| Cash Flow per share - trailing 12 month | 4.000 |
| Dividend per share - most recent fiscal year | 1.560 |
| Dividends per share - trailing 12 month | 1.420 |
| EBITD per share - trailing 12 month | 4.217 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 1.340 |
| EPS Basic excluding extraordinary items - trailing 12 month | 1.340 |
| EPS including extraordinary items - most recent fiscal year | 1.340 |
| EPS including extraordinary items - trailing 12 month | 1.340 |
| Free Cash Flow per share - trailing 12 month | 2.797 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 16.24 |
| P/E Normalized, most recent fiscal year | 9.80 |
| Price to sales - most recent fiscal year | 0.65 |
| Price to Tangible Book - most fiscal year | — |
| Price to Free Cash Flow per Share - most recent fiscal year | 7.61 |
| Price to Cash Flow per share - trailing 12 month | 5.32 |
| Price to Book - most recent fiscal year | 1.65 |
| P/E excluding extraordinary items high, trailing 12 months | 16.89 |
| P/E excluding extraordinary items low, trailing 12 months | 10.00 |
| Net Debt, LFI | 6,608.00 |
| Net Debt, LFY | 7,056.00 |
| Dividend Yield - 5 Year Average | 3.71% |
| Dividend Yield - indicated annual dividend divided by closing price | 7.26% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 6.68% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 839.00 |
| LT debt/equity - most recent fiscal year | 165.29% |
| Payout ratio - most recent fiscal year | 119.08% |
| Total debt/total equity - most recent fiscal year | 193.41% |
| LT debt/equity - most recent quarter | 152.51% |
| Total debt/total equity - most recent quarter | 173.95% |
| Free Cash Flow - trailing 12 month | 839.00 |
| Payout ratio - trailing 12 month | 119.08% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 9,744.00 |
| Revenue - trailing 12 month | 9,744.00 |
| EBITD - most recent fiscal year | 1,265.00 |
| EBITD - trailing 12 month | 1,265.00 |
| Earnings before taxes - most recent fiscal year | 529.00 |
| Earnings before taxes - trailing 12 month | 529.00 |
| Net Income available to common - most recent fiscal year | 403.00 |
| Net Income available to common - trailing 12 months | 403.00 |
| Earnings before taxes Normalized - most recent fiscal year | 909.00 |
| Net Income Available to Common, Normalized - most recent fiscal year | 652.00 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 2.17 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 4.16% |
| Net Profit Margin % - trailing 12 month | 4.16% |
| Operating margin - 1st historical fiscal year | 10.77% |
| Operating margin - trailing 12 month | 10.77% |
| Pretax margin - trailing 12 month | 5.43% |
| Pretax margin - 1st historical fiscal year | 5.43% |
| Operating Margin - 5 year average | 12.82% |
| Pretax Margin - 5 year average | 8.90% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 9.78% |
| Free Operating Cash Flow/Revenue, TTM | 8.61% |
| Net Profit Margin - 5 year average | 6.78% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 2.66% |
| Return on average assets - trailing 12 month | 2.66% |
| Return on average equity - most recent fiscal year | 10.26% |
| Return on average equity - trailing 12 month | 10.26% |
| Return on average assets - 5 year average | 5.42% |
| Return on average equity - 5 year average | 19.76% |
| Net Income/employee - most recent fiscal year | 29,562.04 |
| Revenue/employee - most recent fiscal year | 711,240.88 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 2.83% |
| EPS growth rate, 5 year | -16.82% |
| Growth rate% - dividend, 3 year | 1.77% |
| Revenue/share (5 yr growth) | 3.17% |
| Growth rate% - Revenue, 3 year | 1.36% |
| Growth rate% - EPS, 3 year | -22.83% |
| Book value per share growth rate, 5 year | 4.42% |
| Capital Spending growth rate, 5 year | 5.59% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | -7.44% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2026 | 2027 | 2028 | 2029 | |||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | JUL 22 | JUL 23 | JUL 24 | JUL 25 | JUL 26 |
| Fiscal year: | 2022 | 2023 | 2024 | 2025 | 2026 |
| Period length: | 52 months | 52 months | 52 months | 53 months | 52 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Over the past 150-plus years, Campbell's has evolved into a leading domestic packaged food manufacturer, with a portfolio that extends beyond its iconic red-and-white labeled canned soup. In fiscal 2026 (July year-end), meals and beveragesaccounted for 61% of its revenue, while snacks accounted for 39%. Beyond its namesake, its brands include Pepperidge Farm, Goldfish, Snyder's of Hanover, Swanson, Pacific Foods, Prego, Pace, V8, and, most recently, Rao's (a deal that closed in 2024). Around 90% of its revenue results from the US and the remainder from Canada and Latin America.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
